Journal News

Starved to death: Can dietary methionine combat cancer?

Nicole Lynn
July 27, 2021

The organic compounds that come together to form proteins are called amino acids. The human body uses amino acids as sources of energy for functions such as homeostasis, growth, and repair. While the body can produce some amino acids (known as nonessential), others are strictly obtained through food (known as essential).

The essential amino acid methionine, or Met, is critical for genetic regulation, protein production, cell metabolism and DNA repair. Unlike noncancerous cells, most cancer cells cannot recycle Met efficiently; instead, cancer cells rely on a continuous supply of methionine from external sources for growth. This vulnerability is known as Met dependence, or Met stress sensitivity.

Researchers do not know much yet about the mechanisms behind Met dependence in cancer; however, a recent study published in the Journal of Lipid Research has brought us closer to understanding the role of Met dependence in cancer cell lipid metabolism. Peter Kaiser of the University of California, Irvine, and collaborators at the University of California, Davis, Metabolomics Center and University of Texas MD Anderson Cancer Center used Met-dependent and Met-independent breast cancer cell lines to characterize the lipid changes that occur in response to Met-dependent stress.

Kaiser Group, University of California, Irvine
This image shows cancer cells (red) starved of methionine. The stress of this deficiency results in accumulation of lipid droplets (yellow) in the cell.

In the cell, diverse lipids make up the cellular membrane and aid in signaling and transport; lipids are also important for nutrient and energy storage. While lipid metabolism is studied widely in relationship to heart disease, researchers know little about lipid metabolism in cancer.

“In cancers, specifically in breast cancer, there has always been a connection to lipid metabolism,” Kaiser said. “We are very interested in understanding how these changes in lipids can affect cancer cells and how they can translate into feasible drug targets.”

Kaiser and colleagues fed cancer cells Met-deficient media to induce stress and then used high-performance liquid chromatography, genetic analysis, and cell microscopy to characterize the changes that occurred in lipids. The researchers found that lipid remodeling and abundance are affected directly by Met-deprivation stress in cancer cells.

Compared to the Met-independent cells (which do not require externally provided Met), the researchers saw an accumulation of lipid droplets, a decrease in lipid synthesis, and a global decrease in all lipid types (except triglycerides; these underwent remodeling), in the Met-dependent cancer cells (which require a continuous external supply of Met). These changes suggest Met stress may affect the endoplasmic reticulum, or ER, an organelle in the cell responsible for many metabolic processes, including lipid synthesis.

“A lot of proteins are folded in the ER,” Kaiser said. “This can lead to a stress response because protein folding becomes impacted in the ER as a consequence of the changes occurring to the lipids.”

These findings support a previous study in which reduced dietary Met helped shrink tumors in rats when used in conjunction with radiation or chemotherapeutics.

Kaiser and his colleagues seek to understand the molecular mechanisms involved in cancer Met dependence. His lab is also interested in the relationship between Met dependence and cell cycle regulation. These studies could increase knowledge of the unique metabolic needs of cancer cells and lead to better therapies.

Enjoy reading ASBMB Today?

Become a member to receive the print edition monthly and the digital edition weekly.

Learn more
Nicole Lynn

Nicole Lynn is a Ph.D. candidate at UCLA and a volunteer writer for ASBMB Today.

Related articles

From the journals: March 2019
John Arnst, Courtney Chandler, Isha Dey & Catherine Goodman
From the journals: August 2018
John Arnst, Sasha Mushegian, Angela Hopp & Laurel Oldach
From the journals: JBC
Ken Farabaugh

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Proteomic clues to oocyte development
Journal News

Proteomic clues to oocyte development

June 7, 2023

Researchers in Nanjing, China, have identified functions of critical proteins and pathways for female germ cell maturation.

Molecular basis for interaction between an essential protein complex and its regulator
News

Molecular basis for interaction between an essential protein complex and its regulator

June 4, 2023

Mutations in COPI are associated with multiple human diseases, including cancers and microcephalies.

UTSW researchers discover how food-poisoning bacteria infect the intestines
News

UTSW researchers discover how food-poisoning bacteria infect the intestines

June 3, 2023

Findings revealing efficient assembly of virulence machine could lead to development of treatments for diseases caused by gut pathogens.

'CoA as the central core'
Interview

'CoA as the central core'

June 2, 2023

ASBMB meeting on CoA and its derivatives will take place in Wisconsin in August and will feature sessions on metabolism, intracellular cross talk, proteostasis, autophagy and technological advances in mass spectrometry.

Study uncovers a unique, efficient method of copper delivery in cells
News

Study uncovers a unique, efficient method of copper delivery in cells

May 28, 2023

Discovery will help in treating Menkes disease, other copper deficiency disorders.

As microbiome science forges ahead, will some be left behind?
Essay

As microbiome science forges ahead, will some be left behind?

May 27, 2023

The FDA’s approval of the first fecal microbiota treatment was a watershed moment — and also a wakeup call.